SCHEMBL27384640

SCHEMBL27384640

CC(C)c1ccc2cc(CNC(=O)N3CCC3)[nH]c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.46
▸ EIF4A3 P38919 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ RAB9A P51151 4/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ BCHE P06276 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ EPHX2 P34913 1/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384644 0.97 MAPK1 (0.46) MAPK1EIF4A3ALDH1A1SMN1; SMN2MEN1
SCHEMBL27384257 0.82 RAB9A (0.50) MAPK1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL27384648 0.80 EIF4A3 (0.48) MAPK1EIF4A3ALDH1A1SMN1; SMN2MEN1
SCHEMBL27382616 0.79 EIF4A3 (0.51) MAPK1EIF4A3ALDH1A1SMN1; SMN2MEN1
SCHEMBL27384259 0.79 KMT2A (0.48) MAPK1ALDH1A1MEN1KMT2ARAB9A
SCHEMBL27247001 0.79 MTNR1A (0.56) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL27384339 0.78 MAPK1 (0.42) MAPK1EIF4A3ALDH1A1SMN1; SMN2MEN1
SCHEMBL27383636 0.78 EIF4A3 (0.47) EIF4A3SMN1; SMN2RAB9ANPC1MTNR1A
SCHEMBL27384655 0.77 EIF4A3 (0.48) MAPK1EIF4A3ALDH1A1SMN1; SMN2MEN1
SCHEMBL27384011 0.77 EIF4A3 (0.46) MAPK1EIF4A3SMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback